EBITDA: Income before interest, taxes, depreciation and amortization.
T2 Biosystems, Inc. (TTOO) had EBITDA of $-9.24M for the most recently reported fiscal quarter, ending 2023-12-31.
| Income Statement Financials | |
$1.68M |
|
$-10.34M |
|
$2.57M |
|
$-0.90M |
|
$11.00M |
|
$-9.32M |
|
$-1.02M |
|
$-10.34M |
|
$-10.34M |
|
$-10.34M |
|
$-10.34M |
|
$-10.34M |
|
$-10.34M |
|
$-9.32M |
|
|
EBITDA |
$-9.24M |
2.61M |
|
2.61M |
|
$124.26 |
|
$124.26 |
|
| Balance Sheet Financials | |
$25.19M |
|
$1.66M |
|
$9.61M |
|
$34.80M |
|
$56.15M |
|
-- |
|
$6.68M |
|
$62.83M |
|
$-28.04M |
|
$-28.04M |
|
$-28.04M |
|
4.06M |
|
| Cash Flow Statement Financials | |
$-48.14M |
|
$-0.19M |
|
$52.69M |
|
$11.88M |
|
$16.24M |
|
$4.36M |
|
$4.35M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.45 |
|
-- |
|
-- |
|
-- |
|
-1.47 |
|
-53.31% |
|
-555.03% |
|
-555.03% |
|
-- |
|
-615.84% |
|
-615.84% |
|
$-48.33M |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
0.53 |
|
1.18 |
|
76.12 |
|
36.88% |
|
36.88% |
|
-29.72% |
|
36.88% |
|
$-6.91 |
|
$-18.52 |
|
$-18.44 |
|